FACIT’s Compass Rose Oncology Fund has invested in DNAstack. FACIT’s Prospects Oncology Fund initially invested in 2017.
Toronto based DNAstack is developing advanced data standards and technologies that make it easier for scientists to find, access, analyze and share complex and large volumes of multi-omics data in the cloud.
Latest posts by CPE Media News (see all)
- Summit Partners backed NetBrain to open Toronto office in April - February 7, 2019
- Renaissance BioScience forms partnership with Mitacs, UBC and University of Manitoba - January 28, 2019
- DNAstack secures new financing from FACIT - January 10, 2019